Historical record - last NADAC publication: 8/23/2023
Product Information
ETHOSUXIMIDE 250 MG/5 ML SOLN is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0780 per ML under NDC 59762235006. Its NADAC has been published 124 times since Apr 21, 2021.
The Low Outlier badge above means this manufacturer's average price in the Ethosuximide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/5mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762235006
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
8/23/2023
Active Ingredients
ETHOSUXIMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA080258On Market Since
2/21/2020
Pharmacological Classes
Price Statistics
The NADAC for ETHOSUXIMIDE 250 MG/5 ML SOLN has been published 124 times since Apr 21, 2021, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0780 per ML |
|---|---|
| All-time high | $0.2177 (Jan 12, 2022) |
| All-time low | $0.0626 (Jul 20, 2022) |
| Median price | $0.0941 |
| Average price | $0.1272 |
| Largest weekly change | -36.7% (May 18, 2022) |
| Weeks tracked | 124 |
| Tracking since | Apr 21, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ETHOSUXIMIDE 250 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ETHOSUXIMIDE 250 MG/5 ML SOLN, manufactured by Mylan Pharmaceuticals Inc., is $0.0780 per ML (NDC 59762235006), effective Aug 30, 2023.
How has the price of ETHOSUXIMIDE 250 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for ETHOSUXIMIDE 250 MG/5 ML SOLN has declined 59.7%. It has been tracked across 124 weekly CMS publications since Apr 21, 2021.
What are the highest and lowest recorded NADAC prices for ETHOSUXIMIDE 250 MG/5 ML SOLN?
Since Apr 21, 2021, the NADAC for ETHOSUXIMIDE 250 MG/5 ML SOLN has ranged from a low of $0.0626 (Jul 20, 2022) to a high of $0.2177 (Jan 12, 2022), with a median of $0.0941 per ML.
Are there cheaper alternatives to ETHOSUXIMIDE 250 MG/5 ML SOLN?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ETHOSUXIMIDE 250 MG/5 ML SOLN, but none are currently priced below it.
Who manufactures ETHOSUXIMIDE 250 MG/5 ML SOLN?
ETHOSUXIMIDE 250 MG/5 ML SOLN (NDC 59762235006) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification